Table 1.

Patient demographics and outcomes of OCDC vaccine treatment

Purity of vaccine
Subject IDAgeStage of diseaseNumber of prior ChemotherapiesNumber of vaccines received%CD86%HLA-DRResponse to vaccine
S148IIIC3392.45%72.42%Progressing disease
S246IV4588.20%71.10%Stable disease
S349IIC2594.97%88.75%Stable disease
S463IIIC7582.20%74.51%Mixed response
S559IIIC2581.11%82.53%Progressing disease